Design, Synthesis and Evaluation of CNS Depressant Activity of 2-(Substituted Aryl)-Piperazine-3-Phenyl-4(3H)-Quinazolinone
Abstract
Anxiety is characterized by excessive fear that persists and interferes with a person's daily activities. In this study, a new class of 16 derivatives of 2-(Substituted Aryl)-piperazine-3-phenyl-4(3H)-quinazolinones were synthesized, and all of the derivatives were tested for their ability to reduce anxiety using the holeboard test and the elevated plus maize test, administered intraperitoneally to mice at doses of 10 mg/kg body weight. Test compounds 3-phenyl-2-(4-(3-methylphenyl) piperazin-1-yl)quinazolin-4(3H)-one (SD-05), 2-(4-(2-fluorophenyl) piperazin-1-yl)-3-phenylquinazolin-4(3H)-one (SD-06), 3-phenyl-2-(4-(4-methoxyphenyl) piperazin-1-yl)-quinazolin-4(3H)-one (SD-10) showed an increased number of head pocking (56 ± 3.5 to 70 ± 1) as compare to control group number of head pocking (27 ± 3) and increased duration of pocking (50 ± 12 ns) as compare to control group duration of pocking (25 ± 2) in hole board test and increased time spent in open arm (35.5 ± 1.5) and a number of entries in open arm (12.5 ± 0.50) as compare to control group. Test compounds SD-05, SD-06, SD-10 showed significant antianxiety activity.
Keywords:
Quinazolinones, Piperazine, Antianxiety, Hole board Test, Elevated Plus Maize Test.DOI
https://doi.org/10.25004/IJPSDR.2023.150213References
Jagdale AS, Amrutkar S V. Substituted Quinazoline a Potential Drug Candidate: An Overview. World Journal of Pharmaceutical Research 2017;6(15): 281-295.doi.10.20959/wjpr201715-10086.
Kashaw SK, Kashaw, V, Mishra P, Jain NK. Design, synthesis and potential CNS activity of some novel 1-(4-substituted-phenyl)-3-(4-oxo-2-propyl-4H-quinazolin-3-yl)-urea. Archive for Organic Chemistry 2008; xiv: 17-26.
Ilangovan P, Ganguly S, Pandi P, Stables JP. Design and Synthesis of Novel Quinazolinone derivatives as Broad-Spectrum Anticonvulsants. Der Pharmacia Lettre 2010; 2(1):13-21.
Koleva V, Yotova I, Dragoeva A, Enchev D. Synthesis, cytotoxicity, and promising anticancer potential of novel β-amino- and β-iminophosphonates. Journal of Applied Pharmaceutical Science 2021; 11(07): 080-088.doi. 10.7324/JAPS.2021.110708
Kadri A, Aoudai K. In vitro antimicrobial and α-glucosidase inhibitory potential of enantiopure cycloalkylglycine derivatives: Insights into their in silico pharmacokinetic, druglikeness, and medicinal chemistry properties. Journal of Applied Pharmaceutical Science 2012; 10(06):107-115.doi. 10.7324/JAPS.2020.10614
Zala SP, Badmanaban R, Sen DJ, Patel CN. Synthesis and biological evaluation of 2,4,5-triphenyl-1H-imidazole-1-yl Derivatives. Journal of Applied Pharmaceutical Science 2012; 02(07): 202- 208.doi.10.7324/JAPS.2012.2732
Dutta A, Sarma D. Recent advances in the synthesis of Quinazoline analogues as Anti-TB agents. Tuberculosis 2020; 124.doi.org/10.1016/j.tube.2020.101986
Ram K, Agrawal P, Sinha M, Mahatao N. Recent Advances on Quinazoline Derivatives: A Potential Bioactive Scaffold in Medicinal Chemistry. Chemengineering 2021; 5(4):73.doi.org./10.3390/chemengineering5040073
Farshid H, Hojjat S, Elham J, Azadeh S, Nasim D. Synthesis and cytotoxic evaluation of some quinazolinone-5-(4-chlorophenyl) 1, 3, 4-oxadiazole conjugates”. Research in Pharmaceutical Science2019;14(5):408–413. Doi.10.4103/1735-5362.268201
Published
Abstract Display: 382 
PDF Downloads: 646 
